| Structure | Chemical Name | CAS | MF |
|
1,1'-biphenyl]-3,3',4,5'-tetracarboxylic acid
|
1868072-45-0
|
C16H10O8
|
|
N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-
fluoro-4-[2-methyl-3-(propan-2-yl)-2H-indazol-5-yl]
pyrimidin-2-amine
|
1868086-40-1
|
C27H33FN8
|
|
Tert-Butyl 2-(Hydroxymethyl)-7,8-Dihydro-1,6-Naphthyridine-6(5H)-Carboxylate(WX141997)
|
1868106-31-3
|
C14H20N2O3
|
|
Levetiracetam Impurity 19
|
1868118-63-1
|
C8H16N2O3
|
|
Sofosbuvir D6
|
1868135-06-1
|
C22H29FN3O9P
|
|
1,3-Benzenedicarboxylic acid,5-[2,6-bis(4-carboxyphenyl)-4-pyridinyl]-
|
1868146-04-6
|
C27H17NO8
|
|
4-(3,5-dimethylphenyl)-2,6-di-p-tolylpyridine
|
1868146-05-7
|
C27H25N
|
|
Naphthalen-1-yl-(4-naphthalen-1-yl-phenyl)-[3-(6-phenyl-dibenzofuran-4-yl)-phenyl]-amine
|
1868149-26-1
|
C50H33NO
|
|
PDS9443
|
1868149-44-3
|
C42H38BNO2
|
|
[(4-Trifluoromethyl)phenyl](2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate
|
1868173-15-2
|
C23H22F3IO6S
|
|
(3,5-Dichlorophenyl)(2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate
|
1868173-25-4
|
C22H21Cl2IO6S
|
|
[4-Fluoro-3-(trifluoromethyl)phenyl](2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate
|
1868173-29-8
|
C23H21F4IO6S
|
|
(5-Fluoro-2-nitrophenyl)(2,4,6-trimethoxyphenyl)iodonium p-Toluenesulfonate
|
1868173-33-4
|
C22H21FINO8S
|
|
4-Biphenylyl(2,4,6-trimethoxyphenyl)iodonium Trifluoromethanesulfonate
|
1868173-47-0
|
C22H20F3IO6S
|
|
A-893
|
1868232-32-9
|
C29H38Cl2N4O4
|
|
Alflutinib
|
1869057-83-9
|
C28H31F3N8O2
|
|
Iopamidol EP impurity F
|
1869069-71-5
|
C16H20I3N3O6
|
|
Iopamidol EP impurity G
|
1869069-72-6
|
C17H22I3N3O8
|
|
Bendamustine D-Mannitol Ester
|
1869075-89-7
|
C22H33Cl2N3O7
|
|
Bendamustine Impurity 9
|
1869075-90-0
|
C22H34Cl3N3O7
|
|
9,10-Didehydroeffususol A
|
1869082-57-4
|
C18H18O3
|
|
Effususol A
|
1869082-58-5
|
C18H20O3
|
|
N-[5-[(4-Methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]carbamic acid ethyl ester
|
1869118-24-0
|
C16H16N4O4S
|
|
1-[(benzyloxy)carbonyl]-4-ethyl-2,5-dihydro-1H-pyrrole-3-carboxylic acid
|
1869118-25-1
|
C15H17NO4
|
|
Azido-PEG4-Val-Cit-PAB-MMAE
|
1869126-64-6
|
C69H113N13O17
|
|
glycoside A
|
1869126-66-8
|
C33H52O8
|
|
2-chloro-4-(naphtho[2,1-b]benzofuran-9-yl)quinazoline
|
1869142-01-7
|
C24H13ClN2O
|
|
2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-(1-methylcyclobutyl)propanoic acid
|
1869480-16-9
|
C23H25NO4
|
|
6-Hydroxypicolinaldehyde
|
1869712-45-7
|
C6H5NO2
|
|
Cyclopentaneacetic acid, 3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-
|
1869824-13-4
|
C22H23NO4
|
|
benzyl N-[(3-oxocyclobutyl)methyl]carbamate
|
1869903-79-6
|
C13H15NO3
|
|
AZD5153
|
1869912-39-9
|
C25H33N7O3
|
|
AZD-5153 HNT salt
|
1869912-40-2
|
C36H41N7O6
|
|
4-(Piperidin-4-yl)phenol hydrobromide
|
1869912-48-0
|
C11H16BrNO
|
|
AA-CW236
|
1869921-96-9
|
C17H16ClF3N4O2
|
|
PC Biotin-PEG3-Alkyne
|
1869922-24-6
|
C35H52N6O12S
|
|
4,4,5,5-Tetramethyl-2-[2-(2-methylpropyl)-phenyl]-1,3,2-dioxaborolane
|
1869934-28-0
|
C16H25BO2
|
|
2-Amino-5-chloro-4-fluoro-benzoic acid ethyl ester
|
1869938-65-7
|
C9H9ClFNO2
|
|
JWH 018 2'-naphthyl-N-(2,2-dimethylpropyl) isomer
|
1869954-38-0
|
C24H23NO
|
|
JWH 018 2naphthyl-N-(1-ethylpropyl) isomer
|
1869959-37-4
|
C24H23NO
|
|
Pyrene maleimide
|
1869968-64-8
|
C26H22N2O3
|
|
YFQNBXNHANIAJR-UHFFFAOYSA-N
|
1869980-05-1
|
C24H23NO2
|
|
DMAc-PPM
|
1870041-75-0
|
C52H42N4
|
|
DMAc-MPM
|
1870041-76-1
|
C47H40N4
|
|
4-Bromo-5-fluoro-2-iodobenzoic acid
|
1870155-80-8
|
C7H3BrFIO2
|
|
5-Pyrimidinecarboxaldehyde, 4,6-dichloro-2-(1-methyl-1H-pyrazol-3-yl)-
|
1870191-92-6
|
C9H6Cl2N4O
|
|
Methanone, (5-bromo-2-chloro-4-pyridinyl)-4-morpholinyl-
|
1870258-51-7
|
C10H10BrClN2O2
|
|
4-Cyclobutoxy-benzoic acid Methyl ester
|
1870333-37-1
|
C12H14O3
|
|
2-{4-[(4-Chlorophenyl)methyl]phenyl}-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
|
1870804-20-8
|
C19H22BClO2
|
|
SLC5111312 (hydrochloride)
|
1870811-01-0
|
C22H28ClN5O3
|
|
Isoquinoline, 4-(3-bromophenyl)-6,8-dichloro-1,2,3,4-tetrahydro-2-methyl-, (4S)-
|
1870821-29-6
|
C16H14BrCl2N
|
|
(2R,3R)-2,3-bis(benzoyloxy)butanedioic acid, (4S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline
|
1870821-30-9
|
C18H14O8.C16H14BrCl2N
|
|
Butanoic acid, 2-[(4-cyano-2-methoxyphenyl)methylene]-3-oxo-, 2-cyanoethyl ester, (2Z)-
|
1870824-80-8
|
C16H14N2O4
|
|
(E)-2-(3,5-dimethyl-4-(phenyldiazenyl)-1H-pyrazol-1-yl)acetic acid
|
1870855-76-7
|
C13H14N4O2
|
|
L-Phenylalanine, 4-cyano-N-[(1,1-dimethylethoxy)carbonyl]-2,6-dimethyl-
|
1870867-59-6
|
C17H22N2O4
|
|
Afatinib Impurity 17
|
1870880-09-3
|
C20H18Cl2FN5O
|
|
1,1'-Bitricyclo[3.3.1.13,7]deca ne, 3,3',5,5',7,7'-hexabromo-
|
1870882-71-5
|
C20 H24 Br6
|
|
1,1'-Bitricyclo[3.3.1.13,7]decane, 3,3' ,5,5',7,7'-hexakis(4-bromophenyl)-
|
1870882-73-7
|
C56 H48 Br6
|
|
Ivabradine Impurity 5
|
1870894-09-9
|
|
|
Azadibenzocyclooctyne-PEG4-acid
|
1870899-46-9
|
C32H40N2O9
|
|
2-chloro-2,4,6-triisopropyl-1,1-biphenyl（WS202134）
|
1870911-65-1
|
C21H27Cl
|
|
Mc-Val-Ala-PAB
|
1870916-87-2
|
C25H34N4O6
|
|
Tert-Butyl 4-Hydroxy-3-Methyl-4-(Trifluoromethyl)Piperidine-1-Carboxylate
|
1871000-15-5
|
C12H20F3NO3
|
|
Methanone, (5-bromo-2-chloro-4-pyridinyl)-4-thiomorpholinyl-
|
1871486-46-2
|
C10H10BrClN2OS
|
|
1-((Benzyloxy)carbonyl)-2-methylpiperidine-3-carboxylic acid
|
1871579-06-4
|
C15H19NO4
|
|
5-chloro-6-methoxynicotinamide
|
1871789-20-6
|
C7H7ClN2O2
|
|
(5-Iodo-1-methyl-1H-pyrazol-4-yl)-methanol
|
1871985-48-6
|
C5H7IN2O
|
|
1,2-bis(4-(pyridin-4-yl)phenyl)diazene
|
1872218-35-3
|
C22H16N4
|
|
Cyclobutanecarboxylic acid, 1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl ester
|
1872262-64-0
|
C13H11NO4
|
|
1,4-Piperidinedicarboxylic acid, 4-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl) 1-(1,1-dimethylethyl) ester
|
1872262-73-1
|
C19H22N2O6
|
|
9H-Carbazole-3,6-dicarboxylic acid, 9-(3,5-dicarboxyphenyl)-
|
1872263-31-4
|
C22H13NO8
|
|
7H-Benzo[b]fluoreno[3,4-d]furan, 5,9-dibromo-7,7-diphenyl-
|
1872364-25-4
|
C31H18Br2O
|
|
1-Palmitoyl-d9-2-Palmitoyl-sn-glycerol
|
1872379-48-0
|
C35H68O5
|
|
UNC3866
|
1872382-47-2
|
C43H66N6O8
|
|
1872383-50-0
|
1872383-50-0
|
C40H38N4
|
|
Hydrazine, [2,?4,?6-?tris(1-?methylethyl)?phenyl]?-?, hydrochloride (1:1)
|
1872384-93-4
|
C15H27ClN2
|
|
DC661
|
1872387-43-3
|
C31H39Cl2N5
|
|
6-methoxy-1-methyl-pyrrolo[2,3-b]pyridine
|
1872392-82-9
|
C9H10N2O
|
|
Kimcuongin
|
1872403-23-0
|
C20H20O6
|
|
1,3,2-Dioxaborolane,4,4,5,5-tertramethyl-2-[1,1":3':1"-terphenyl]-2-yl-
|
1872426-73-7
|
C24H25BO2
|
|
1,1,1-Trifluoroethyl-PEG5-Tos
|
1872433-61-8
|
C17H25F3O7S
|
|
M-Peg4-phosphonic acid
|
1872433-62-9
|
C9H21O7P
|
|
Propargyl-PEG4-(CH2)3-methyl ester
|
1872433-63-0
|
C14H24O6
|
|
t-Boc-Aminooxy-PEG4-t-butyl ester
|
1872433-64-1
|
C20H39NO9
|
|
1,1,1-Trifluoroethyl-PEG4-amine
|
1872433-72-1
|
C10H20F3NO4
|
|
m-PEG4-phosphonic acid ethyl ester
|
1872433-73-2
|
C13H29O7P
|
|
Propargyl-PEG4-(CH2)3-acid
|
1872433-74-3
|
C13H22O6
|
|
(Des-Gly10,D-His2,D-Ser(tBu)6,Pro-NHEt9)-LHRH
|
1872434-99-5
|
C60H86N16O13
|
|
Leuprorelin EP Impurity F
|
1872435-00-1
|
C59H84N16O12
|
|
(Des-Gly10,D-His2,D-Trp6,Pro-NHET9)-lhrh
|
1872435-01-2
|
C64H83N17O12
|
|
Dnp-(Leu421)-Collagen Type VIII α1 Chain (419-426) amide (human, mouse) trifluoroacetate salt
|
1872435-02-3
|
C40H64N14O12S
|
|
LIP1 (human)
|
1872435-03-4
|
C133H229N45O37
|
|
Neuronostatin-13 (mouse, rat), H-Leu-Arg-Gln-Phe-Leu-Gln-Lys-Ser-Leu-Ala-Ala-Ala-Thr-NH2, trifluoroacetate
|
1872435-05-6
|
C65H112N20O17
|
|
Neuronostatin-19 (human, canine, porcine)
|
1872435-06-7
|
C90H151N29O25
|
|
Osteoblast Activating Peptide (human)
|
1872435-08-9
|
C120H196N38O37S
|
|
Coagulation factor II receptor-like 2 (1-6) amide (human)
|
1872435-09-0
|
C29H46N10O7
|
|
H-Glu-Cys-Leu-Trp-Met-Asp-Trp-Val-Thr-Glu-Lys-Asn-Ile-Asn-Gly-His-Gln-Ala-Lys-Phe-Phe-Ala-Cys-Ile-OH, (disulfide bond)
|
1872435-10-3
|
C131H189N33O35S3
|
|
|
(Biotinyl-Cys1,Lys(biotinyl)18)-calcitonin (human)
|
1872440-39-5
|
|
|
|
Biotinyl-εAhx-Amyloid β-Protein (1-42)
|
1872440-40-8
|
|
|
|
LIP2 (human)
|
1872440-46-4
|
|